QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Eyes Significant Interest Since Full Launch of Evolve(TM)
SenesTech (NASDAQ: SNES), a rodent fertility control expert and the innovator of the only EPA-registered contraceptive for male and female rats, recently released its financial results for the 2023 financial year. “Of note was the 80% year-to-date (‘YTD’) revenue growth and the 45.2% year-over-year (‘YOY’) growth in gross profit, a significant milestone which Joel Fruendt, president and CEO of SenesTech, attributed to the development of Evolve(TM), the company’s all-new soft bait product,” a recent article reads. “Since the full launch of Evolve in January 2024, we have seen a significant uptick in interest and orders from a wide range of…